Table 1.
Patient | Age | Sex | NV conflict | Target | Dose (Gy) | Total follow-up (months) | Result at 3 months | Result at last follow-up | Subsequent Treatment |
---|---|---|---|---|---|---|---|---|---|
1 | 83 | F | Yes | GPM | 60 | 7 | Class I | Class V | Repeat GKR |
GPM | 70 | 10 | Class I | Class V | TC twice | ||||
2 | 62 | M | No | Cistern | 70 | 24 | Class IV | Class V | CS |
3 | 66 | M | Yes | Cistern | 70 | 24 | Class IV | Class V | MVD |
4 | 49 | M | No | GPM | 75 | 32 | Class I | Class I | None |
5 | 71 | M | Yes | GPM | 80 | 13 | Class I | Class II | None |
6 | 36 | F | No | GPM | 80 | 10 | Class I | Class I | None |
7 | 65 | M | Yes | GPM | 80 | 8 | Class I | Class II | None |
Cistern: Cisternal segment of the glossopharyngeal nerve, Class I: Pain-free without medication, Class II: Pain-free with medication, Class IV: Pain frequency reduction between 50 to 90%, Class V: No significant reduction in pain frequency, CS: Cortical stimulator, F: Female, GKR: Gamma Knife radiosurgery, GPM: Distal part of the glossopharyngeal nerve at the glossopharyngeal meatus of the jugular foramen, Gy: Gray, M: Male, MVD: Microvascular decompression, NV: Neurovascular, TC: Thermocoagulation.